메뉴 건너뛰기




Volumn 12, Issue 11, 2016, Pages 1132-1148

An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation

Author keywords

Alzheimer's disease; Amyloid ; Biomarker; Blood; Down syndrome; Inflammation; Metallo proteases; MMP 3; MMP 9; Nerve growth factor; Plasma; proNGF

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; METALLOPROTEINASE; NERVE GROWTH FACTOR; NEUROSERPIN; PRO NERVE GROWTH FACTOR; PROTEINASE; STROMELYSIN; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); BIOLOGICAL MARKER; CYTOKINE; MMP3 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; NEUROPEPTIDE; PEPTIDE FRAGMENT; PRO-NERVE GROWTH FACTOR, HUMAN; PROTEIN PRECURSOR; SERINE PROTEINASE INHIBITOR;

EID: 84994472229     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2016.05.001     Document Type: Article
Times cited : (73)

References (103)
  • 1
    • 0037433652 scopus 로고    scopus 로고
    • Down's syndrome
    • [1] Roizen, N.J., Patterson, D., Down's syndrome. Lancet 361 (2003), 1281–1289.
    • (2003) Lancet , vol.361 , pp. 1281-1289
    • Roizen, N.J.1    Patterson, D.2
  • 2
    • 84860330689 scopus 로고    scopus 로고
    • Neurological phenotypes for Down syndrome across the life span
    • [2] Lott, I.T., Neurological phenotypes for Down syndrome across the life span. Prog Brain Res 197 (2012), 101–121.
    • (2012) Prog Brain Res , vol.197 , pp. 101-121
    • Lott, I.T.1
  • 3
    • 0023889961 scopus 로고
    • The pathological association between Down syndrome and Alzheimer disease
    • [3] Mann, D.M., The pathological association between Down syndrome and Alzheimer disease. Mech Ageing Dev 43 (1988), 99–136.
    • (1988) Mech Ageing Dev , vol.43 , pp. 99-136
    • Mann, D.M.1
  • 4
    • 0022919237 scopus 로고
    • The topography of plaques and tangles in Down's syndrome patients of different ages
    • [4] Mann, D.M., Yates, P.O., Marcyniuk, B., Ravindra, C.R., The topography of plaques and tangles in Down's syndrome patients of different ages. Neuropathol Appl Neurobiol 12 (1986), 447–457.
    • (1986) Neuropathol Appl Neurobiol , vol.12 , pp. 447-457
    • Mann, D.M.1    Yates, P.O.2    Marcyniuk, B.3    Ravindra, C.R.4
  • 5
    • 0021956826 scopus 로고
    • Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome
    • [5] Wisniewski, K.E., Wisniewski, H.M., Wen, G.Y., Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 17 (1985), 278–282.
    • (1985) Ann Neurol , vol.17 , pp. 278-282
    • Wisniewski, K.E.1    Wisniewski, H.M.2    Wen, G.Y.3
  • 6
    • 0002849850 scopus 로고    scopus 로고
    • Aging and Alzheimer's disease in Down syndrome: Clinical and pathological changes
    • [6] Zigman, W., Silverman, W., Wisniewski, H.M., Aging and Alzheimer's disease in Down syndrome: Clinical and pathological changes. Ment Retard Dev Disabil Res Rev 2 (1996), 73–79.
    • (1996) Ment Retard Dev Disabil Res Rev , vol.2 , pp. 73-79
    • Zigman, W.1    Silverman, W.2    Wisniewski, H.M.3
  • 8
    • 0021827834 scopus 로고
    • Abnormalities of the nucleus basalis in Down's syndrome
    • [8] Casanova, M.F., Walker, L.C., Whitehouse, P.J., Price, D.L., Abnormalities of the nucleus basalis in Down's syndrome. Ann Neurol 18 (1985), 310–313.
    • (1985) Ann Neurol , vol.18 , pp. 310-313
    • Casanova, M.F.1    Walker, L.C.2    Whitehouse, P.J.3    Price, D.L.4
  • 9
    • 0030022841 scopus 로고    scopus 로고
    • Prevalence of dementia in adults with and without Down syndrome
    • [9] Zigman, W.B., Schupf, N., Sersen, E., Silverman, W., Prevalence of dementia in adults with and without Down syndrome. Am J Ment Retard 100 (1996), 403–412.
    • (1996) Am J Ment Retard , vol.100 , pp. 403-412
    • Zigman, W.B.1    Schupf, N.2    Sersen, E.3    Silverman, W.4
  • 11
    • 0024370171 scopus 로고
    • A prospective study of Alzheimer disease in Down syndrome
    • [11] Lai, F., Williams, R.S., A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 46 (1989), 849–853.
    • (1989) Arch Neurol , vol.46 , pp. 849-853
    • Lai, F.1    Williams, R.S.2
  • 14
    • 84863224067 scopus 로고    scopus 로고
    • Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot
    • [14] Hampel, H., Lista, S., Khachaturian, Z.S., Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot. Alzheimers Dement 8 (2012), 312–336.
    • (2012) Alzheimers Dement , vol.8 , pp. 312-336
    • Hampel, H.1    Lista, S.2    Khachaturian, Z.S.3
  • 15
    • 34447322271 scopus 로고    scopus 로고
    • Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria
    • [15] Dubois, B., Feldman, H.H., Jacova, C., Dekosky, S.T., Barberger-Gateau, P., Cummings, J., et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6 (2007), 734–746.
    • (2007) Lancet Neurol , vol.6 , pp. 734-746
    • Dubois, B.1    Feldman, H.H.2    Jacova, C.3    Dekosky, S.T.4    Barberger-Gateau, P.5    Cummings, J.6
  • 17
    • 79956098248 scopus 로고    scopus 로고
    • Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
    • [17] Sperling, R.A., Aisen, P.S., Beckett, L.A., Bennett, D.A., Craft, S., Fagan, A.M., et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7 (2011), 280–292.
    • (2011) Alzheimers Dement , vol.7 , pp. 280-292
    • Sperling, R.A.1    Aisen, P.S.2    Beckett, L.A.3    Bennett, D.A.4    Craft, S.5    Fagan, A.M.6
  • 18
    • 84896712004 scopus 로고    scopus 로고
    • Searching for disease-modifying drugs in AD: can we combine neuropsychological tools with biological markers?
    • [18] Caraci, F., Castellano, S., Salomone, S., Drago, F., Bosco, P., Di Nuovo, S., Searching for disease-modifying drugs in AD: can we combine neuropsychological tools with biological markers?. CNS Neurol Disord Drug Targets 13 (2014), 173–186.
    • (2014) CNS Neurol Disord Drug Targets , vol.13 , pp. 173-186
    • Caraci, F.1    Castellano, S.2    Salomone, S.3    Drago, F.4    Bosco, P.5    Di Nuovo, S.6
  • 19
    • 0023009645 scopus 로고
    • Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease
    • [19] Etienne, P., Robitaille, Y., Wood, P., Gauthier, S., Nair, N.P., Quirion, R., Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease. Neuroscience 19 (1986), 1279–1291.
    • (1986) Neuroscience , vol.19 , pp. 1279-1291
    • Etienne, P.1    Robitaille, Y.2    Wood, P.3    Gauthier, S.4    Nair, N.P.5    Quirion, R.6
  • 20
    • 0021059767 scopus 로고
    • Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase
    • [20] Pearson, R.C., Sofroniew, M.V., Cuello, A.C., Powell, T.P., Eckenstein, F., Esiri, M.M., et al. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res 289 (1983), 375–379.
    • (1983) Brain Res , vol.289 , pp. 375-379
    • Pearson, R.C.1    Sofroniew, M.V.2    Cuello, A.C.3    Powell, T.P.4    Eckenstein, F.5    Esiri, M.M.6
  • 21
    • 0024449354 scopus 로고
    • Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain
    • [21] Mufson, E.J., Bothwell, M., Kordower, J.H., Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain. Exp Neurol 105 (1989), 221–232.
    • (1989) Exp Neurol , vol.105 , pp. 221-232
    • Mufson, E.J.1    Bothwell, M.2    Kordower, J.H.3
  • 22
    • 0033809884 scopus 로고    scopus 로고
    • Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease
    • [22] Mufson, E.J., Ma, S.Y., Cochran, E.J., Bennett, D.A., Beckett, L.A., Jaffar, S., et al. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol 427 (2000), 19–30.
    • (2000) J Comp Neurol , vol.427 , pp. 19-30
    • Mufson, E.J.1    Ma, S.Y.2    Cochran, E.J.3    Bennett, D.A.4    Beckett, L.A.5    Jaffar, S.6
  • 24
    • 0020072221 scopus 로고
    • Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain
    • [24] Whitehouse, P.J., Price, D.L., Struble, R.G., Clark, A.W., Coyle, J.T., Delon, M.R., Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215 (1982), 1237–1239.
    • (1982) Science , vol.215 , pp. 1237-1239
    • Whitehouse, P.J.1    Price, D.L.2    Struble, R.G.3    Clark, A.W.4    Coyle, J.T.5    Delon, M.R.6
  • 25
    • 0017133142 scopus 로고
    • Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies
    • [25] Bowen, D.M., Smith, C.B., White, P., Davison, A.N., Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99 (1976), 459–496.
    • (1976) Brain , vol.99 , pp. 459-496
    • Bowen, D.M.1    Smith, C.B.2    White, P.3    Davison, A.N.4
  • 26
    • 0011162190 scopus 로고
    • Selective loss of central cholinergic neurons in Alzheimer's disease
    • [26] Davies, P., Maloney, A.J., Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet, 2, 1976, 1403.
    • (1976) Lancet , vol.2 , pp. 1403
    • Davies, P.1    Maloney, A.J.2
  • 27
    • 0021264594 scopus 로고
    • Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes
    • [27] Mann, D.M., Yates, P.O., Marcyniuk, B., Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes. Neuropathol Appl Neurobiol 10 (1984), 185–207.
    • (1984) Neuropathol Appl Neurobiol , vol.10 , pp. 185-207
    • Mann, D.M.1    Yates, P.O.2    Marcyniuk, B.3
  • 28
    • 0033616613 scopus 로고    scopus 로고
    • A nerve growth factor mimetic TrkA antagonist causes withdrawal of cortical cholinergic boutons in the adult rat
    • [28] Debeir, T., Saragovi, H.U., Cuello, A.C., A nerve growth factor mimetic TrkA antagonist causes withdrawal of cortical cholinergic boutons in the adult rat. Proc Natl Acad Sci U S A 96 (1999), 4067–4072.
    • (1999) Proc Natl Acad Sci U S A , vol.96 , pp. 4067-4072
    • Debeir, T.1    Saragovi, H.U.2    Cuello, A.C.3
  • 29
    • 0030447321 scopus 로고    scopus 로고
    • Effects of trophic factors on the CNS cholinergic phenotype
    • [29] Cuello, A.C., Effects of trophic factors on the CNS cholinergic phenotype. Prog Brain Res 109 (1996), 347–358.
    • (1996) Prog Brain Res , vol.109 , pp. 347-358
    • Cuello, A.C.1
  • 31
    • 73349089956 scopus 로고    scopus 로고
    • Increased matrix metalloproteinase 9 activity in mild cognitive impairment
    • [31] Bruno, M.A., Mufson, E.J., Wuu, J., Cuello, A.C., Increased matrix metalloproteinase 9 activity in mild cognitive impairment. J Neuropathol Exp Neurol 68 (2009), 1309–1318.
    • (2009) J Neuropathol Exp Neurol , vol.68 , pp. 1309-1318
    • Bruno, M.A.1    Mufson, E.J.2    Wuu, J.3    Cuello, A.C.4
  • 32
    • 84894541662 scopus 로고    scopus 로고
    • Nerve growth factor metabolic dysfunction in Down's syndrome brains
    • [32] Iulita, M.F., Do Carmo, S., Ower, A.K., Fortress, A.M., Aguilar, L.F., Hanna, M., et al. Nerve growth factor metabolic dysfunction in Down's syndrome brains. Brain 137 (2014), 860–872.
    • (2014) Brain , vol.137 , pp. 860-872
    • Iulita, M.F.1    Do Carmo, S.2    Ower, A.K.3    Fortress, A.M.4    Aguilar, L.F.5    Hanna, M.6
  • 33
    • 84903318473 scopus 로고    scopus 로고
    • Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome
    • [33] Iulita, M.F., Cuello, A.C., Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome. Trends Pharmacol Sci 35 (2014), 338–348.
    • (2014) Trends Pharmacol Sci , vol.35 , pp. 338-348
    • Iulita, M.F.1    Cuello, A.C.2
  • 34
    • 84953455893 scopus 로고    scopus 로고
    • The NGF metabolic pathway in the CNS and its dysregulation in Down syndrome and Alzheimer's disease
    • [34] Iulita, M.F., Cuello, A.C., The NGF metabolic pathway in the CNS and its dysregulation in Down syndrome and Alzheimer's disease. Curr Alzheimer Res 13 (2016), 53–67.
    • (2016) Curr Alzheimer Res , vol.13 , pp. 53-67
    • Iulita, M.F.1    Cuello, A.C.2
  • 35
    • 33646241085 scopus 로고    scopus 로고
    • Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade
    • [35] Bruno, M.A., Cuello, A.C., Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. Proc Natl Acad Sci U S A 103 (2006), 6735–6740.
    • (2006) Proc Natl Acad Sci U S A , vol.103 , pp. 6735-6740
    • Bruno, M.A.1    Cuello, A.C.2
  • 36
    • 0015965912 scopus 로고
    • Human memory and the cholinergic system. A relationship to aging?
    • [36] Drachman, D.A., Leavitt, J., Human memory and the cholinergic system. A relationship to aging?. Arch Neurol 30 (1974), 113–121.
    • (1974) Arch Neurol , vol.30 , pp. 113-121
    • Drachman, D.A.1    Leavitt, J.2
  • 37
    • 0001360461 scopus 로고
    • Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
    • [37] Griffin, W.S., Stanley, L.C., Ling, C., White, L., MacLeod, V., Perrot, L.J., et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A 86 (1989), 7611–7615.
    • (1989) Proc Natl Acad Sci U S A , vol.86 , pp. 7611-7615
    • Griffin, W.S.1    Stanley, L.C.2    Ling, C.3    White, L.4    MacLeod, V.5    Perrot, L.J.6
  • 38
    • 84858208717 scopus 로고    scopus 로고
    • Neuroinflammation in the aging Down syndrome brain; lessons from Alzheimer's disease
    • [38] Wilcock, D.M., Neuroinflammation in the aging Down syndrome brain; lessons from Alzheimer's disease. Curr Gerontol Geriatr Res, 2012, 2012, 170276.
    • (2012) Curr Gerontol Geriatr Res , vol.2012 , pp. 170276
    • Wilcock, D.M.1
  • 39
    • 79954486783 scopus 로고    scopus 로고
    • Does a pro-inflammatory process precede Alzheimer's disease and mild cognitive impairment?
    • [39] Ferretti, M.T., Cuello, A.C., Does a pro-inflammatory process precede Alzheimer's disease and mild cognitive impairment?. Curr Alzheimer Res 8 (2011), 164–174.
    • (2011) Curr Alzheimer Res , vol.8 , pp. 164-174
    • Ferretti, M.T.1    Cuello, A.C.2
  • 41
    • 33748471099 scopus 로고    scopus 로고
    • Inflammation in Alzheimer disease: driving force, bystander or beneficial response?
    • [41] Wyss-Coray, T., Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat Med 12 (2006), 1005–1015.
    • (2006) Nat Med , vol.12 , pp. 1005-1015
    • Wyss-Coray, T.1
  • 42
    • 84940467398 scopus 로고    scopus 로고
    • Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease
    • [42] Wilcock, D.M., Hurban, J., Helman, A.M., Sudduth, T.L., McCarty, K.L., Beckett, T.L., et al. Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease. Neurobiol Aging 36 (2015), 2468–2474.
    • (2015) Neurobiol Aging , vol.36 , pp. 2468-2474
    • Wilcock, D.M.1    Hurban, J.2    Helman, A.M.3    Sudduth, T.L.4    McCarty, K.L.5    Beckett, T.L.6
  • 43
    • 84859143780 scopus 로고    scopus 로고
    • Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer's disease-like amyloid pathology
    • [43] Ferretti, M.T., Allard, S., Partridge, V., Ducatenzeiler, A., Cuello, A.C., Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer's disease-like amyloid pathology. J Neuroinflammation, 9, 2012, 62.
    • (2012) J Neuroinflammation , vol.9 , pp. 62
    • Ferretti, M.T.1    Allard, S.2    Partridge, V.3    Ducatenzeiler, A.4    Cuello, A.C.5
  • 44
    • 84861183285 scopus 로고    scopus 로고
    • Intracellular Abeta-oligomers and early inflammation in a model of Alzheimer's disease
    • [44] Ferretti, M.T., Bruno, M.A., Ducatenzeiler, A., Klein, W.L., Cuello, A.C., Intracellular Abeta-oligomers and early inflammation in a model of Alzheimer's disease. Neurobiol Aging 33 (2012), 1329–1342.
    • (2012) Neurobiol Aging , vol.33 , pp. 1329-1342
    • Ferretti, M.T.1    Bruno, M.A.2    Ducatenzeiler, A.3    Klein, W.L.4    Cuello, A.C.5
  • 46
    • 0028834682 scopus 로고
    • Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture
    • [46] Gottschall, P.E., Yu, X., Bing, B., Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture. J Neurosci Res 42 (1995), 335–342.
    • (1995) J Neurosci Res , vol.42 , pp. 335-342
    • Gottschall, P.E.1    Yu, X.2    Bing, B.3
  • 47
    • 0028934085 scopus 로고
    • Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes
    • [47] Gottschall, P.E., Yu, X., Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem 64 (1995), 1513–1520.
    • (1995) J Neurochem , vol.64 , pp. 1513-1520
    • Gottschall, P.E.1    Yu, X.2
  • 48
    • 0031889386 scopus 로고    scopus 로고
    • Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states
    • [48] Pagenstecher, A., Stalder, A.K., Kincaid, C.L., Shapiro, S.D., Campbell, I.L., Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol 152 (1998), 729–741.
    • (1998) Am J Pathol , vol.152 , pp. 729-741
    • Pagenstecher, A.1    Stalder, A.K.2    Kincaid, C.L.3    Shapiro, S.D.4    Campbell, I.L.5
  • 49
    • 0026660964 scopus 로고
    • Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9
    • [49] Ogata, Y., Enghild, J.J., Nagase, H., Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 267 (1992), 3581–3584.
    • (1992) J Biol Chem , vol.267 , pp. 3581-3584
    • Ogata, Y.1    Enghild, J.J.2    Nagase, H.3
  • 50
    • 0003515548 scopus 로고
    • Dementia Scale for Down Syndrome: Manual
    • Gedye Research and Consulting Vancouver, BC
    • [50] Gedye, A., Dementia Scale for Down Syndrome: Manual. 1995, Gedye Research and Consulting, Vancouver, BC.
    • (1995)
    • Gedye, A.1
  • 52
    • 0003582141 scopus 로고
    • International Statistical Classification of Diseases and Related Health Problems
    • World Health Organization Geneva, Switzerland 2010 ed
    • [52] WHO. International Statistical Classification of Diseases and Related Health Problems. 1992, World Health Organization, Geneva, Switzerland 2010 ed.
    • (1992)
  • 54
    • 41149105045 scopus 로고    scopus 로고
    • Maladaptive behaviors related to dementia status in adults with Down syndrome
    • [54] Urv, T.K., Zigman, W.B., Silverman, W., Maladaptive behaviors related to dementia status in adults with Down syndrome. Am J Ment Retard 113 (2008), 73–86.
    • (2008) Am J Ment Retard , vol.113 , pp. 73-86
    • Urv, T.K.1    Zigman, W.B.2    Silverman, W.3
  • 56
    • 84861939416 scopus 로고    scopus 로고
    • Mild cognitive impairment identified in older individuals with Down syndrome by reduced telomere signal numbers and shorter telomeres measured in microns
    • [56] Jenkins, E.C., Ye, L., Velinov, M., Krinsky-McHale, S.J., Zigman, W.B., Schupf, N., et al. Mild cognitive impairment identified in older individuals with Down syndrome by reduced telomere signal numbers and shorter telomeres measured in microns. Am J Med Genet B Neuropsychiatr Genet 159B (2012), 598–604.
    • (2012) Am J Med Genet B Neuropsychiatr Genet , vol.159B , pp. 598-604
    • Jenkins, E.C.1    Ye, L.2    Velinov, M.3    Krinsky-McHale, S.J.4    Zigman, W.B.5    Schupf, N.6
  • 57
    • 0026628073 scopus 로고
    • The Test for Severe Impairment: an instrument for the assessment of patients with severe cognitive dysfunction
    • [57] Albert, M., Cohen, C., The Test for Severe Impairment: an instrument for the assessment of patients with severe cognitive dysfunction. J Am Geriatr Soc 40 (1992), 449–453.
    • (1992) J Am Geriatr Soc , vol.40 , pp. 449-453
    • Albert, M.1    Cohen, C.2
  • 58
    • 0031711528 scopus 로고    scopus 로고
    • Cognitive decline in Down syndrome: a validity/reliability study of the test for severe impairment
    • [58] Cosgrave, M.P., McCarron, M., Anderson, M., Tyrrell, J., Gill, M., Lawlor, B.A., Cognitive decline in Down syndrome: a validity/reliability study of the test for severe impairment. Am J Ment Retard 103 (1998), 193–197.
    • (1998) Am J Ment Retard , vol.103 , pp. 193-197
    • Cosgrave, M.P.1    McCarron, M.2    Anderson, M.3    Tyrrell, J.4    Gill, M.5    Lawlor, B.A.6
  • 59
    • 0023194048 scopus 로고
    • The Modified Mini-Mental State (3MS) examination
    • [59] Teng, E.L., Chui, H.C., The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 48 (1987), 314–318.
    • (1987) J Clin Psychiatry , vol.48 , pp. 314-318
    • Teng, E.L.1    Chui, H.C.2
  • 61
    • 0025257612 scopus 로고
    • Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
    • [61] Hixson, J.E., Vernier, D.T., Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31 (1990), 545–548.
    • (1990) J Lipid Res , vol.31 , pp. 545-548
    • Hixson, J.E.1    Vernier, D.T.2
  • 62
    • 11144354439 scopus 로고    scopus 로고
    • Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease
    • [62] Anello, G., Gueant-Rodriguez, R.M., Bosco, P., Gueant, J.L., Romano, A., Namour, B., et al. Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease. Neuroreport 15 (2004), 859–861.
    • (2004) Neuroreport , vol.15 , pp. 859-861
    • Anello, G.1    Gueant-Rodriguez, R.M.2    Bosco, P.3    Gueant, J.L.4    Romano, A.5    Namour, B.6
  • 64
    • 0034006042 scopus 로고    scopus 로고
    • Commercial recombinant human beta-nerve growth factor and adult rat dorsal root ganglia contain an identical molecular species of nerve growth factor prohormone
    • [64] Reinshagen, M., Geerling, I., Eysselein, V.E., Adler, G., Huff, K.R., Moore, G.P., et al. Commercial recombinant human beta-nerve growth factor and adult rat dorsal root ganglia contain an identical molecular species of nerve growth factor prohormone. J Neurochem 74 (2000), 2127–2133.
    • (2000) J Neurochem , vol.74 , pp. 2127-2133
    • Reinshagen, M.1    Geerling, I.2    Eysselein, V.E.3    Adler, G.4    Huff, K.R.5    Moore, G.P.6
  • 65
    • 84941066690 scopus 로고    scopus 로고
    • A Pro-Nerve Growth Factor (proNGF) and NGF Binding Protein, alpha2-Macroglobulin, Differentially Regulates p75 and TrkA Receptors and Is Relevant to Neurodegeneration Ex Vivo and In Vivo
    • [65] Barcelona, P.F., Saragovi, H.U., A Pro-Nerve Growth Factor (proNGF) and NGF Binding Protein, alpha2-Macroglobulin, Differentially Regulates p75 and TrkA Receptors and Is Relevant to Neurodegeneration Ex Vivo and In Vivo. Mol Cell Biol 35 (2015), 3396–3408.
    • (2015) Mol Cell Biol , vol.35 , pp. 3396-3408
    • Barcelona, P.F.1    Saragovi, H.U.2
  • 66
    • 84994404215 scopus 로고    scopus 로고
    • Early and late inflammation in Alzheimer's pathology. 13th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy Geneva, Switzerland: Neurobiology of Aging;. p. S5.
    • [66] Cuello AC. Early and late inflammation in Alzheimer's pathology. 13th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy Geneva, Switzerland: Neurobiology of Aging; 2014. p. S5.
    • (2014)
    • Cuello, A.C.1
  • 67
    • 32344440522 scopus 로고    scopus 로고
    • Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease
    • [67] Simard, A.R., Soulet, D., Gowing, G., Julien, J.P., Rivest, S., Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49 (2006), 489–502.
    • (2006) Neuron , vol.49 , pp. 489-502
    • Simard, A.R.1    Soulet, D.2    Gowing, G.3    Julien, J.P.4    Rivest, S.5
  • 68
    • 0032213445 scopus 로고    scopus 로고
    • Inflammation and Alzheimer's disease: relationships between pathogenic mechanisms and clinical expression
    • [68] Eikelenboom, P., Rozemuller, J.M., van Muiswinkel, F.L., Inflammation and Alzheimer's disease: relationships between pathogenic mechanisms and clinical expression. Exp Neurol 154 (1998), 89–98.
    • (1998) Exp Neurol , vol.154 , pp. 89-98
    • Eikelenboom, P.1    Rozemuller, J.M.2    van Muiswinkel, F.L.3
  • 69
    • 0023633015 scopus 로고
    • Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR
    • [69] McGeer, P.L., Itagaki, S., Tago, H., McGeer, E.G., Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 79 (1987), 195–200.
    • (1987) Neurosci Lett , vol.79 , pp. 195-200
    • McGeer, P.L.1    Itagaki, S.2    Tago, H.3    McGeer, E.G.4
  • 70
    • 84908191011 scopus 로고    scopus 로고
    • Intracellular Abeta pathology and early cognitive impairments in a transgenic rat overexpressing human amyloid precursor protein: a multidimensional study
    • [70] Iulita, M.F., Allard, S., Richter, L., Munter, L.M., Ducatenzeiler, A., Weise, C., et al. Intracellular Abeta pathology and early cognitive impairments in a transgenic rat overexpressing human amyloid precursor protein: a multidimensional study. Acta Neuropathol Commun, 2, 2014, 61.
    • (2014) Acta Neuropathol Commun , vol.2 , pp. 61
    • Iulita, M.F.1    Allard, S.2    Richter, L.3    Munter, L.M.4    Ducatenzeiler, A.5    Weise, C.6
  • 71
    • 0036316012 scopus 로고    scopus 로고
    • Chemokines and pro-inflammatory cytokines in Down's syndrome: an early marker for Alzheimer-type dementia?
    • [71] Carta, M.G., Serra, P., Ghiani, A., Manca, E., Hardoy, M.C., Del Giacco, G.S., et al. Chemokines and pro-inflammatory cytokines in Down's syndrome: an early marker for Alzheimer-type dementia?. Psychother Psychosom 71 (2002), 233–236.
    • (2002) Psychother Psychosom , vol.71 , pp. 233-236
    • Carta, M.G.1    Serra, P.2    Ghiani, A.3    Manca, E.4    Hardoy, M.C.5    Del Giacco, G.S.6
  • 72
    • 14844327741 scopus 로고    scopus 로고
    • Altered cytokine and acute phase response protein levels in the blood of children with Downs syndrome: relationship with dementia of Alzheimer's type
    • [72] Licastro, F., Chiappelli, M., Ruscica, M., Carnelli, V., Corsi, M.M., Altered cytokine and acute phase response protein levels in the blood of children with Downs syndrome: relationship with dementia of Alzheimer's type. Int J Immunopathol Pharmacol 18 (2005), 165–172.
    • (2005) Int J Immunopathol Pharmacol , vol.18 , pp. 165-172
    • Licastro, F.1    Chiappelli, M.2    Ruscica, M.3    Carnelli, V.4    Corsi, M.M.5
  • 74
    • 77953020162 scopus 로고    scopus 로고
    • A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment
    • [74] Leon, W.C., Canneva, F., Partridge, V., Allard, S., Ferretti, M.T., DeWilde, A., et al. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment. J Alzheimers Dis 20 (2010), 113–126.
    • (2010) J Alzheimers Dis , vol.20 , pp. 113-126
    • Leon, W.C.1    Canneva, F.2    Partridge, V.3    Allard, S.4    Ferretti, M.T.5    DeWilde, A.6
  • 75
    • 84938689993 scopus 로고    scopus 로고
    • The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer's Disease
    • [75] Pimentel, L.S., Allard, S., Do Carmo, S., Weinreb, O., Danik, M., Hanzel, C.E., et al. The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer's Disease. J Alzheimers Dis 47 (2015), 373–383.
    • (2015) J Alzheimers Dis , vol.47 , pp. 373-383
    • Pimentel, L.S.1    Allard, S.2    Do Carmo, S.3    Weinreb, O.4    Danik, M.5    Hanzel, C.E.6
  • 76
    • 85026789694 scopus 로고    scopus 로고
    • Intraneuronal Amyloid Beta Accumulation Disrupts Hippocampal CRTC1-Dependent Gene Expression and Cognitive Function in a Rat Model of Alzheimer Disease
    • [E-pub ahead of print]
    • [76] Wilson, E.N., Abela, A.R., Do Carmo, S., Allard, S., Marks, A.R., Welikovitch, L.A., et al. Intraneuronal Amyloid Beta Accumulation Disrupts Hippocampal CRTC1-Dependent Gene Expression and Cognitive Function in a Rat Model of Alzheimer Disease. Cereb Cortex, 2016 [E-pub ahead of print].
    • (2016) Cereb Cortex
    • Wilson, E.N.1    Abela, A.R.2    Do Carmo, S.3    Allard, S.4    Marks, A.R.5    Welikovitch, L.A.6
  • 78
    • 84880117155 scopus 로고    scopus 로고
    • Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis
    • [78] Wilcock, D.M., Griffin, W.S., Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis. J Neuroinflammation, 10, 2013, 84.
    • (2013) J Neuroinflammation , vol.10 , pp. 84
    • Wilcock, D.M.1    Griffin, W.S.2
  • 79
    • 2942536284 scopus 로고    scopus 로고
    • Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease
    • [79] Peng, S., Wuu, J., Mufson, E.J., Fahnestock, M., Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. J Neuropathol Exp Neurol 63 (2004), 641–649.
    • (2004) J Neuropathol Exp Neurol , vol.63 , pp. 641-649
    • Peng, S.1    Wuu, J.2    Mufson, E.J.3    Fahnestock, M.4
  • 80
    • 84856986118 scopus 로고    scopus 로고
    • Impact of the NGF maturation and degradation pathway on the cortical cholinergic system phenotype
    • [80] Allard, S., Leon, W.C., Pakavathkumar, P., Bruno, M.A., Ribeiro-da-Silva, A., Cuello, A.C., Impact of the NGF maturation and degradation pathway on the cortical cholinergic system phenotype. J Neurosci 32 (2012), 2002–2012.
    • (2012) J Neurosci , vol.32 , pp. 2002-2012
    • Allard, S.1    Leon, W.C.2    Pakavathkumar, P.3    Bruno, M.A.4    Ribeiro-da-Silva, A.5    Cuello, A.C.6
  • 82
  • 83
    • 62649160992 scopus 로고    scopus 로고
    • Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain
    • [83] Fabbro, S., Seeds, N.W., Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain. J Neurochem 109 (2009), 303–315.
    • (2009) J Neurochem , vol.109 , pp. 303-315
    • Fabbro, S.1    Seeds, N.W.2
  • 84
    • 0346463111 scopus 로고    scopus 로고
    • Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains
    • [84] Ledesma, M.D., Abad-Rodriguez, J., Galvan, C., Biondi, E., Navarro, P., Delacourte, A., et al. Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains. EMBO Rep 4 (2003), 1190–1196.
    • (2003) EMBO Rep , vol.4 , pp. 1190-1196
    • Ledesma, M.D.1    Abad-Rodriguez, J.2    Galvan, C.3    Biondi, E.4    Navarro, P.5    Delacourte, A.6
  • 85
    • 84901928902 scopus 로고    scopus 로고
    • Analysis of matrix metallo-proteases and the plasminogen system in mild cognitive impairment and Alzheimer's disease cerebrospinal fluid
    • [85] Hanzel, C.E., Iulita, M.F., Eyjolfsdottir, H., Hjorth, E., Schultzberg, M., Eriksdotter, M., et al. Analysis of matrix metallo-proteases and the plasminogen system in mild cognitive impairment and Alzheimer's disease cerebrospinal fluid. J Alzheimers Dis 40 (2014), 667–678.
    • (2014) J Alzheimers Dis , vol.40 , pp. 667-678
    • Hanzel, C.E.1    Iulita, M.F.2    Eyjolfsdottir, H.3    Hjorth, E.4    Schultzberg, M.5    Eriksdotter, M.6
  • 86
    • 0032722442 scopus 로고    scopus 로고
    • The plasminogen (fibrinolytic) system
    • [86] Collen, D., The plasminogen (fibrinolytic) system. Thromb Haemost 82 (1999), 259–270.
    • (1999) Thromb Haemost , vol.82 , pp. 259-270
    • Collen, D.1
  • 87
    • 77957321489 scopus 로고    scopus 로고
    • Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease
    • [87] Horstmann, S., Budig, L., Gardner, H., Koziol, J., Deuschle, M., Schilling, C., et al. Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease. Int Psychogeriatr 22 (2010), 966–972.
    • (2010) Int Psychogeriatr , vol.22 , pp. 966-972
    • Horstmann, S.1    Budig, L.2    Gardner, H.3    Koziol, J.4    Deuschle, M.5    Schilling, C.6
  • 88
    • 0026442957 scopus 로고
    • Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders
    • [88] Gijbels, K., Masure, S., Carton, H., Opdenakker, G., Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J Neuroimmunol 41 (1992), 29–34.
    • (1992) J Neuroimmunol , vol.41 , pp. 29-34
    • Gijbels, K.1    Masure, S.2    Carton, H.3    Opdenakker, G.4
  • 89
    • 78650699283 scopus 로고    scopus 로고
    • Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review
    • [89] Ramos-Fernandez, M., Bellolio, M.F., Stead, L.G., Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review. J Stroke Cerebrovasc Dis 20 (2011), 47–54.
    • (2011) J Stroke Cerebrovasc Dis , vol.20 , pp. 47-54
    • Ramos-Fernandez, M.1    Bellolio, M.F.2    Stead, L.G.3
  • 90
    • 0037418038 scopus 로고    scopus 로고
    • Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke
    • [90] Montaner, J., Molina, C.A., Monasterio, J., Abilleira, S., Arenillas, J.F., Ribo, M., et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 107 (2003), 598–603.
    • (2003) Circulation , vol.107 , pp. 598-603
    • Montaner, J.1    Molina, C.A.2    Monasterio, J.3    Abilleira, S.4    Arenillas, J.F.5    Ribo, M.6
  • 92
    • 0033950591 scopus 로고    scopus 로고
    • Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain
    • [92] Yoshiyama, Y., Asahina, M., Hattori, T., Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain. Acta Neuropathol 99 (2000), 91–95.
    • (2000) Acta Neuropathol , vol.99 , pp. 91-95
    • Yoshiyama, Y.1    Asahina, M.2    Hattori, T.3
  • 93
    • 33845977715 scopus 로고    scopus 로고
    • A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation
    • [93] Kim, Y.S., Choi, D.H., Block, M.L., Lorenzl, S., Yang, L., Kim, Y.J., et al. A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation. FASEB J 21 (2007), 179–187.
    • (2007) FASEB J , vol.21 , pp. 179-187
    • Kim, Y.S.1    Choi, D.H.2    Block, M.L.3    Lorenzl, S.4    Yang, L.5    Kim, Y.J.6
  • 94
    • 34447275455 scopus 로고    scopus 로고
    • Elevated plasma beta-amyloid peptide Abeta(42) levels, incident dementia, and mortality in Down syndrome
    • [94] Schupf, N., Patel, B., Pang, D., Zigman, W.B., Silverman, W., Mehta, P.D., et al. Elevated plasma beta-amyloid peptide Abeta(42) levels, incident dementia, and mortality in Down syndrome. Arch Neurol 64 (2007), 1007–1013.
    • (2007) Arch Neurol , vol.64 , pp. 1007-1013
    • Schupf, N.1    Patel, B.2    Pang, D.3    Zigman, W.B.4    Silverman, W.5    Mehta, P.D.6
  • 95
    • 84947787127 scopus 로고    scopus 로고
    • Semantic Verbal Fluency Pattern, Dementia Rating Scores and Adaptive Behavior Correlate With Plasma Abeta42 Concentrations in Down Syndrome Young Adults
    • [95] Hoyo, L.D., Xicota, L., Sanchez-Benavides, G., Cuenca-Royo, A., de Sola, S., Langohr, K., et al. Semantic Verbal Fluency Pattern, Dementia Rating Scores and Adaptive Behavior Correlate With Plasma Abeta42 Concentrations in Down Syndrome Young Adults. Front Behav Neurosci, 9, 2015, 301.
    • (2015) Front Behav Neurosci , vol.9 , pp. 301
    • Hoyo, L.D.1    Xicota, L.2    Sanchez-Benavides, G.3    Cuenca-Royo, A.4    de Sola, S.5    Langohr, K.6
  • 97
    • 84875250937 scopus 로고    scopus 로고
    • Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
    • [97] Villemagne, V.L., Burnham, S., Bourgeat, P., Brown, B., Ellis, K.A., Salvado, O., et al. Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol 12 (2013), 357–367.
    • (2013) Lancet Neurol , vol.12 , pp. 357-367
    • Villemagne, V.L.1    Burnham, S.2    Bourgeat, P.3    Brown, B.4    Ellis, K.A.5    Salvado, O.6
  • 98
    • 80052266213 scopus 로고    scopus 로고
    • The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
    • [98] Karran, E., Mercken, M., De Strooper, B., The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10 (2011), 698–712.
    • (2011) Nat Rev Drug Discov , vol.10 , pp. 698-712
    • Karran, E.1    Mercken, M.2    De Strooper, B.3
  • 99
    • 0027021888 scopus 로고
    • Molecular characterization and measurement of Alzheimer's disease pathology: implications for genetic and environmental aetiology
    • discussion 293–302
    • [99] Wischik, C.M., Harrington, C.R., Mukaetova-Ladinska, E.B., Novak, M., Edwards, P.C., McArthur, F.K., Molecular characterization and measurement of Alzheimer's disease pathology: implications for genetic and environmental aetiology. Ciba Found Symp 169 (1992), 268–293 discussion 293–302.
    • (1992) Ciba Found Symp , vol.169 , pp. 268-293
    • Wischik, C.M.1    Harrington, C.R.2    Mukaetova-Ladinska, E.B.3    Novak, M.4    Edwards, P.C.5    McArthur, F.K.6
  • 100
    • 77952316871 scopus 로고    scopus 로고
    • Cognitive deficits and associated neurological complications in individuals with Down's syndrome
    • [100] Lott, I.T., Dierssen, M., Cognitive deficits and associated neurological complications in individuals with Down's syndrome. Lancet Neurol 9 (2010), 623–633.
    • (2010) Lancet Neurol , vol.9 , pp. 623-633
    • Lott, I.T.1    Dierssen, M.2
  • 101
    • 85074109354 scopus 로고    scopus 로고
    • The Down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in Down syndrome
    • [101] Rafii, M.S., Wishnek, H., Brewer, J.B., Donohue, M.C., Ness, S., Mobley, W.C., et al. The Down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in Down syndrome. Front Behav Neurosci, 9, 2015, 239.
    • (2015) Front Behav Neurosci , vol.9 , pp. 239
    • Rafii, M.S.1    Wishnek, H.2    Brewer, J.B.3    Donohue, M.C.4    Ness, S.5    Mobley, W.C.6
  • 102
    • 84907055448 scopus 로고    scopus 로고
    • Pro: Are we ready to translate Alzheimer's disease modifying therapies to people with Down syndrome?
    • [102] Rafii, M.S., Pro: Are we ready to translate Alzheimer's disease modifying therapies to people with Down syndrome?. Alzheimers Res Ther, 6, 2014, 60.
    • (2014) Alzheimers Res Ther , vol.6 , pp. 60
    • Rafii, M.S.1
  • 103
    • 84907063733 scopus 로고    scopus 로고
    • Con: are we ready to translate Alzheimer's disease-modifying therapies to people with Down syndrome?
    • [103] Head, E., Schmitt, F.A., Con: are we ready to translate Alzheimer's disease-modifying therapies to people with Down syndrome?. Alzheimers Res Ther, 6, 2014, 61.
    • (2014) Alzheimers Res Ther , vol.6 , pp. 61
    • Head, E.1    Schmitt, F.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.